FDA Backs New Morning-After Pill

Fueling the fire over what some have called an “abortion pill,” the Food and Drug Administration approved a longer-lasting contraceptive pill Thursday. The drug, named ella by the French company behind it, aims to prevent ovulation for five days after unprotected intercourse, which is two more days than the currently available “morning-after pill,” Plan B. The FDA deemed ella a safe option, and said that its efficacy data were “compelling.” "Every woman deserves a last chance to prevent pregnancy," said a Princeton University population expert. But unlike Plan B, which women over the age of 17 can buy over the counter, ella would require a prescription if it hits the American market. It is already available in 22 countries.